Arimidex 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. The Arimidex tablet is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.
The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.
If you are allergic to Anastrozole or its ingredients, tell your doctor before starting treatment with this medication. Tell your doctor if you are still experiencing menstruation and have not yet reached menopause, have osteoporosis, or have any liver or kidney problems. If you are lactose intolerant, consult your doctor before taking this medicine. Do not take medicine if you are pregnant or breastfeeding.
Applies to Arimidex 1mg TabletsArimidex 1mg Tablet
Brand: Arimidex
Generic: Anastrozole 1mg Tablet
Do not take Arimidex 1mg Tablet if:
Also, ask your doctor if you are intolerant to taking:
If you are taking anastrozole (as anastrozole 1mg tablet, Generic, Anastrozole 1mg Tablet), tell your doctor immediately.
Arimidex 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. The Arimidex tablet is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.
The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.
If you are allergic to Anastrozole or its ingredients, tell your doctor before starting treatment with this medication. Tell your doctor if you are still experiencing menstruation and have not yet reached menopause, have osteoporosis, or have any liver or kidney problems. If you are lactose intolerant, consult your doctor before taking this medicine. Do not take medicine if you are pregnant or breastfeeding.
How common is the use of Arimidex 1mg tablets?There is no cure for breast cancer, but treatment can help reduce the risk of getting it. Arimidex 1mg tablets are a cancer treatment in which adipose tissue in the treated area is replaced by a hormone that reduces the production of estrogen. This side effect is called non-gonad-based cancer. Doctors only prescribe Arimidex 1mg tablets based on your specific case. While Arimidex 1mg tablets are not recommended for women, they may be prescribed for you if you have:tumours of the uterus or abnormal (especially the growth of the membranes lining the uterus) or if you are breastfeeding.
You should always speak to your doctor before taking any medicine to treat your symptoms or to prevent signs of your cancer from coming back. Your doctor will monitor you regularly during treatment with Arimidex 1mg tablets.
How long has Arimidex 1mg been used?The most recent year for which such an online consultation can be offered was 2016. However, due to insufficient data from small trials, such forms of online consultation are not available.
Arimidex 1mg tablets are used as second- or third-line treatment for breast cancer in postmenopausal women with hormone-dependent breast cancer.
How do I store my Arimidex 1mg?You should keep all medicine out of the reach of children. To ensure the accuracy of online consultation forms, we suggest that you use the formatic approach: Check the “What next?” section of theig the questionnaire. This will help you to determine if your form is safe and appropriate for your specific condition.
How long did my doctor/ dentist take to look after my Arimidex 1mg?Arimidex 1mg tablets are available in a quantity of 2 tablets. An additional 2 tablets are required for your dentist to administer. It is essential that you keep the medicine in your office, clinic, or physician’s usual cabinet for storage.
What does Arimidex 1mg cost?The cost of Arimidex 1mg can vary depending on your local pharmacy and insurance coverage. Ask your doctor or pharmacist if you can discuss your local cost with your doctor or pharmacist. Arimidex 1mg tablets can be split between you and your doctor/ dentist if insurance doesn't cover the cost. If insurance doesn't cover the cost, you may need a doctor’s prescription to get your Arimidex 1mg.
To find out about your costs, talk to your doctor or pharmacist.
More information:16 Jan 2015
What is Arimidex 1mg?Arimidex 1mg is an aromatase inhibitor that lowers estrogen levels in women with hormone-sensitive breast cancer. It works by blocking an enzyme in adipose tissue, which reduces the production of estrogen. Arimidex 1mg can be used to treat hormone-sensitive breast cancer in postmenopausal women with hormone-sensitive breast cancer. (APA)
Arimidex 1mg Tablet is a prescription medicine used to treat hormone-dependent breast cancer in postmenopausal women with hormone-sensitive breast cancer.Arimidex Tablet is a prescription medicine used to treat hormone-dependent breast cancer in postmenopausal women with hormone-sensitive breast cancer. It lowers estrogen levels in women with breast cancer.
Medically reviewed by
Medically reviewed by. Last updated on Oct 23, 2024.
Anastrozole versus ArimidexEffectivenessClinical trials have generally demonstrated that the use of anastrozole may be an effective treatment for breast cancer. However, more research is needed to determine the long-term effectiveness of this strategy in preventing recurrence. In a randomized, double-blind, placebo-controlled trial comparing the effectiveness of Arimidex and Anastrozole in treating hormone receptor positive (HR+) breast cancer, patients with a positive hormone receptor status were randomized to receive either 2 mg anastrozole daily or placebo, every day for 6 months. The primary end point was the rate of breast cancer recurrence.
The primary objective of the study was to compare the rates of breast cancer recurrence and death following treatment with Anastrozole versus Arimidex.
Study DesignThis trial included a randomized, double-blind, placebo-controlled trial with a planned duration of 6 months. The study design is intended to be a randomized, double-blinded, placebo-controlled trial, in which the primary end point was the risk of recurrence and recurrence-free survival. The study participants were either patients with hormone receptor-positive (HR+) breast cancer who received Anastrozole or anastrozole and received the same dose of placebo as patients with HR+ breast cancer, who received a combination of Anastrozole and Arimidex as part of their treatment plan.
In addition, the study protocol included a multicentre, randomized, placebo-controlled, parallel-group, non-comparative analysis.
Participants were eligible if they were at least 18 years old and had undergone a previous mammogram and had a positive hormone receptor status prior to their enrollment in the study. A baseline assessment was performed before randomization. Participants were required to be at least 18 years old and have a positive hormone receptor status prior to inclusion in the study. Patients were excluded if they had been diagnosed with a primary malignant breast cancer before the study began, had a positive mammogram prior to the study beginning, or had an intact breast. Participants were also excluded if they had received prior radiotherapy and had a history of or had had breast cancer within the last three months. Participants were also excluded if they had a history of ovarian cancer or had a history of breast cancer, had a history of blood clots, or had received hormone therapy prior to the study. The study was conducted at the Department of Obstetrics and Gynecology of the University of Pittsburgh Medical Center and was approved by the College of Physicians and Medical Sciences of the Pittsburgh University.
All study participants signed informed consent forms. The primary study outcomes were the primary end point of the study and the secondary end point of recurrence and death following the completion of the study treatment. The primary end point of the study was the risk of recurrence and recurrence-free survival following completion of the study treatment. The secondary end point of the study was the risk of recurrence and recurrence-free survival following completion of the study treatment.
Participants completed the study treatment and were followed for a minimum of 12 months. After the study treatment, participants were screened for any clinically significant contraindications. An assessment of the benefit and risks of the study treatment was performed to ensure eligibility for the study. If patients did not have a clinical interview with the investigator after completing the study, an additional evaluation of the benefit and risks of the study treatment was performed. If participants reported that they would like to have a second opinion regarding the benefits and risks of the study treatment, an additional evaluation of the benefit and risks of the study treatment was performed.
Study medication was administered via intramuscular injection once a day for 1 week, every day for 6 months. During the study treatment, participants were instructed to perform a breast self-examination every day. Following each dose of study medication, participants completed a question that included their breast size and number.
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Shared videos on how to use this productHealthylife ship with a 3 time free supply (3 days 30 day or 6 month ).
3-7 working daysdepending on your order.
Healthylife ship with a 3 time free return. Once you have attached a case, there will be no returns on this product.
The information provided on this website is intended as a general guide for purchasing medicine. It should not be used to provide personalized, non-branded, or exceptionally sensitive product information or to indicate a replacement for the original one due to possible harm or loss. The content is not intended to be considered an advice or diagnosis. Always consult your doctor or other qualified healthcare providers before using any medication.
Stade de France Pharmacy